23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › TWIST BIOSCIENCE CORP. › 2023-2024

TWIST BIOSCIENCE CORP. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and TWIST BIOSCIENCE CORP.’s Form 8-K, filed February 7, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 4Ballot items
  • 259Asset managers, any item
  • 1,270Fund votes
  • February 6, 2024Meeting date

Results at a glance

Meeting of February 6, 2024: 4 items on TWIST BIOSCIENCE CORP.’s Form 8-K, filed February 7, 2024: 2 approved · 2 passed (calculated).

Dissent

Significant dissent: 2 directors (40.4%, 26.4% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TWIST BIOSCIENCE CORP. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by TWIST BIOSCIENCE CORP.

These tallies are TWIST BIOSCIENCE CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed February 7, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TWIST BIOSCIENCE CORP. — official shareholder meeting results, meeting held February 6, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Emily M. Leproust, Ph.D. 33,957,330---- 12,194,8296,148,005 74%Passed (calculated)—
Elect Director: Robert Chess 27,503,789---- 18,648,3706,148,005 60%Passed (calculated)—
2. Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs") 43,215,5712,904,71431,874 --6,148,005 94%Approved—
3. Ratification of Appointment of Independent Registered Accounting Firm 52,195,31861,54843,298 ---- 99.9%Approved—

Source: TWIST BIOSCIENCE CORP., Form 8-K, filed with the SEC on February 7, 2024 — read the filing on EDGAR.

How asset managers voted at the TWIST BIOSCIENCE CORP. 2023-2024 meeting

259 asset managers disclosed a vote on at least one TWIST BIOSCIENCE CORP. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Emily M. Leproust, Ph.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 5 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%WITHHELD
FOR: 33,957,330WITHHELD: 12,194,829
Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: Election of Class III Directors: Emily M. Leproust, Ph.D.

TWIST BIOSCIENCE CORP.’s own tally for this item (“Elect Director: Emily M. Leproust, Ph.D.”): 33,957,330 for, 12,194,829 withheld, per its Form 8-K filed February 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 22,396,067 for, 3,079,222 withheld, 51,348 abstained.

FOR
FOR: 22,396,067ABSTAIN: 51,348WITHHOLD: 3,079,222
Largest asset managers voting on “Election of Class III Directors: Emily M. Leproust, Ph.D.” at TWIST BIOSCIENCE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust6,775,4450 00For
Vanguard5,376,1440 00For
State Street1,993,3540 01,380For
Artisan1,611,9320 00For
Invesco1,365,1500 00For
BlackRock1,223,0590 00For
BNY Mellon882,3940 00For
Dimensional00 0859,476Withhold
JPMorgan782,8270 00For
WILLIAM BLAIR FUNDS00 0756,519Withhold
Charles Schwab448,2320 00For
AIG/SunAmerica00 0264,245Withhold
Bridge Builder Trust244,3620 12,0390For
Fidelity63,0350 0181,306Mixed
Direxion Shares ETF Trust00 0229,799Withhold
OLD WESTBURY FUNDS INC00 0216,180Withhold
Brighthouse179,2240 09,465Mixed
Equitable112,4690 059,444Mixed
TIAA168,6710 00For
Jackson National141,2140 12,9310Mixed
AMERICAN BEACON FUNDS138,1460 00For
Columbia Threadneedle132,7000 00For
FRANKLIN STRATEGIC SERIES119,8620 00For
Global X104,3200 00For
First Trust00 096,906Withhold

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

Elect Director: Robert Chess

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

60% Majority: yes · of votes cast

FOR 60%WITHHELD
FOR: 27,503,789WITHHELD: 18,648,370
Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: Election of Class III Directors: Robert Chess

TWIST BIOSCIENCE CORP.’s own tally for this item (“Elect Director: Robert Chess”): 27,503,789 for, 18,648,370 withheld, per its Form 8-K filed February 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 60% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 17,450,548 for, 7,883,527 withheld, 192,562 abstained.

FORWITHHOLD
FOR: 17,450,548ABSTAIN: 192,562WITHHOLD: 7,883,527
Largest asset managers voting on “Election of Class III Directors: Robert Chess” at TWIST BIOSCIENCE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust6,775,4450 00For
Vanguard5,376,1440 00For
State Street1,2430 01,993,491Withhold
Artisan1,611,9320 00For
Invesco00 01,365,150Withhold
BlackRock1,223,0590 00For
BNY Mellon00 0882,394Withhold
Dimensional00 0859,476Withhold
JPMorgan782,8270 00For
WILLIAM BLAIR FUNDS00 0756,519Withhold
Charles Schwab448,2320 00For
AIG/SunAmerica00 0264,245Withhold
Bridge Builder Trust244,3620 12,0390For
Fidelity63,0350 0181,306Mixed
Direxion Shares ETF Trust00 0229,799Withhold
OLD WESTBURY FUNDS INC00 0216,180Withhold
Brighthouse00 0188,689Withhold
Equitable112,4690 059,444Mixed
TIAA168,6710 00For
Jackson National00 154,1450Abstain
AMERICAN BEACON FUNDS138,1460 00For
Columbia Threadneedle00 0132,700Withhold
FRANKLIN STRATEGIC SERIES119,8620 00For
Global X25,9870 078,333Mixed
First Trust00 096,906Withhold

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs")

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 14 wordings of this item as funds reported it.

94% Approved · of votes cast

FOR 94%
FOR: 43,215,571AGAINST: 2,904,714
Details: description as filed, official tally, votes by 256 asset managers

Description as filed by funds: To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation."

TWIST BIOSCIENCE CORP.’s own tally for this item (“2. Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs")”): 43,215,571 for, 2,904,714 against — passed, per its Form 8-K filed February 7, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Two — Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs") The Company's stockholders approved, on a non-binding and advisory basis, a resolution approving the compensation of the Company's NEOs by the following votes:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 74 asset managers voting on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Offic” at TWIST BIOSCIENCE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust6,775,4450 00For
Vanguard5,376,1440 00For
Artisan4,556,3710 00For
State Street1,994,7340 00For
Invesco1,365,1500 00For
BlackRock1,223,0590 00For
BNY Mellon0882,394 00Against
Dimensional859,4760 00For
JPMorgan782,8270 00For
WILLIAM BLAIR FUNDS756,5190 00For
Charles Schwab448,2320 00For
AIG/SunAmerica264,2450 00For
Bridge Builder Trust256,4010 00For
Fidelity244,3410 00For
Direxion Shares ETF Trust229,7990 00For
OLD WESTBURY FUNDS INC216,1800 00For
Brighthouse188,6890 00For
Equitable171,9130 00For
TIAA168,6710 00For
Jackson National154,1450 00For
AMERICAN BEACON FUNDS138,1460 00For
Columbia Threadneedle132,7000 00For
FRANKLIN STRATEGIC SERIES119,8620 00For
Global X104,3200 00For
First Trust96,9060 00For

Fund voting reports, all 74 managers: 27,582,111 for, 882,394 against, 7,164 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 202 asset managers voting on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Offic” at TWIST BIOSCIENCE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Nikko Asset Management Americas, Inc.3,236,3550 00For
State Street3,068,8010 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC2,827,1750 00For
Maryland State Retirement & Pension System2,000,0000 00For
JPMorgan1,905,5710 00For
BlackRock1,864,6410 00For
Man Group plc1,637,7400 00For
UBS01,165,195 00Against
Invesco1,116,4610 00For
Newton Investment Management North America, LLC0979,393 00Against
Citadel571,4120 00For
BAILLIE GIFFORD & CO LTD565,9000 00For
Charles Schwab448,2320 00For
NORDEA INVESTMENT MANAGEMENT AB0377,148 00Against
NEW YORK STATE COMMON RETIREMENT FUND370,8490 00For
Nikko Asset Management Co., Ltd.347,0880 00For
Ensign Peak Advisors, Inc262,9430 00For
Rafferty Asset Management, LLC229,7990 00For
GEODE CAPITAL MANAGEMENT, LLC184,4180 00For
Nuveen178,0040 00For
Goldman Sachs172,2630 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC165,8120 00For
FRANKLIN ADVISERS INC154,6660 00For
LORD, ABBETT & CO. LLC151,6150 00For
Dimensional149,1370 00For

Institutional-manager reports, all 202 managers: 23,596,648 for, 2,757,324 against, 2,902 abstained, 1,264 not voted, 45 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of Appointment of Independent Registered Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 52,195,318AGAINST: 61,548
Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2024.

TWIST BIOSCIENCE CORP.’s own tally for this item (“3. Ratification of Appointment of Independent Registered Accounting Firm”): 52,195,318 for, 61,548 against — passed, per its Form 8-K filed February 7, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Three — Ratification of Appointment of Independent Registered Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered accounting firm for the fiscal year ending September 30, 2024 by the following votes:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 25,519,473 for, 7,164 abstained.

FOR
FOR: 25,519,473ABSTAIN: 7,164
Largest asset managers voting on “RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCA” at TWIST BIOSCIENCE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust6,775,4450 00For
Vanguard5,376,1440 00For
State Street1,994,7340 00For
Artisan1,611,9320 00For
Invesco1,365,1500 00For
BlackRock1,223,0590 00For
BNY Mellon882,3940 00For
Dimensional859,4760 00For
JPMorgan782,8270 00For
WILLIAM BLAIR FUNDS756,5190 00For
Charles Schwab448,2320 00For
AIG/SunAmerica264,2450 00For
Bridge Builder Trust256,4010 00For
Fidelity244,3410 00For
Direxion Shares ETF Trust229,7990 00For
OLD WESTBURY FUNDS INC216,1800 00For
Brighthouse188,6890 00For
Equitable171,9130 00For
TIAA168,6710 00For
Jackson National154,1450 00For
AMERICAN BEACON FUNDS138,1460 00For
Columbia Threadneedle132,7000 00For
FRANKLIN STRATEGIC SERIES119,8620 00For
Global X104,3200 00For
First Trust96,9060 00For

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

Largest TWIST BIOSCIENCE CORP. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 57,779,000 shares outstanding at the time of that meeting.

Fund voting reports: top TWIST BIOSCIENCE CORP. shareholders by shares voted on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named…”, 2023-2024
#Asset manager % of shares outstanding
1ARK ETF Trust 11.73%
2Vanguard 9.30%
3Artisan 7.89%
4State Street 3.45%
5Invesco 2.36%
6BlackRock 2.12%
7BNY Mellon 1.53%
8Dimensional 1.49%
9JPMorgan 1.35%
10WILLIAM BLAIR FUNDS 1.31%
Institutional-manager reports: top TWIST BIOSCIENCE CORP. shareholders by shares voted on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named…”, 2023-2024
#Asset manager % of shares outstanding
1Nikko Asset Management Americas, Inc. 5.60%
2State Street 5.31%
3WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 4.89%
4Maryland State Retirement & Pension System 3.46%
5JPMorgan 3.30%
6BlackRock 3.23%
7Man Group plc 2.83%
8UBS 2.02%
9Invesco 1.93%
10Newton Investment Management North America, LLC 1.70%

Reported TWIST BIOSCIENCE CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

TWIST BIOSCIENCE CORP. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
ARK Investment Management LLC7,213,257 12.48%Schedule 13G, filed January 29, 2024
BlackRock6,178,376 10.69%Form 13F, quarter ended March 31, 2024
Vanguard Group5,768,149 9.98%Form 13F, quarter ended March 31, 2024
State Street Corporation4,426,429 7.66%Proxy statement (DEF 14A), proxy filed January 5, 2024
JPMorgan Chase & Co.3,829,962 6.63%Proxy statement (DEF 14A), proxy filed January 5, 2024
William Blair Investment Management, LLC3,549,874 6.14%Schedule 13G, filed February 12, 2024
FMR LLC3,087,060 5.34%Proxy statement (DEF 14A), proxy filed January 5, 2024
Nikko Asset Management Americas, Inc.2,934,033 5.08%Proxy statement (DEF 14A), proxy filed January 5, 2024
Invesco2,455,974 4.25%Form 13F, quarter ended March 31, 2024
Millennium Management2,224,031 3.85%Form 13F, quarter ended March 31, 2024

Percentages above are of 57,779,000 shares outstanding, as reported by TWIST BIOSCIENCE CORP. on its Form 10-Q dated December 31, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At TWIST BIOSCIENCE CORP.'s shareholder meeting held February 6, 2024, in the 2023-2024 proxy season, 259 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 1,270 separate fund positions. On the most widely held item on that ballot — To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named… — TWIST BIOSCIENCE CORP.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: TWIST BIOSCIENCE CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on February 7, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TWIST BIOSCIENCE CORP.’s 10-Q dated December 31, 2023. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

TWIST BIOSCIENCE CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “TWIST BIOSCIENCE (TWST) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/twist-bioscience-corp/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.